U.S. Clinical Laboratory Tests Market - Industry Outlook & Forecast 2024-2029
THE U.S. CLINICAL LABORATORY TESTS MARKET IS GROWING AT A CAGR OF 2.17% AND IT IS EXPECTED TO REACH USD 109.09 BILLION BY 2029 FROM USD 95.89 BILLION IN 2023 DURING THE FORECAST PERIOD.
The U.S. Clinical Laboratory Tests Market Size, Share, & Trends Analysis Report By Test Complexity, By Providers, By Test Type - Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2029
Published Date : January 2024
Last Updated : August 2025
format: PDF
edition : Second Edition
186 pages
34 tables
78 charts
1 region
1 countries
17 company
3 segments
Purchase Options
U.S. Clinical Laboratory Tests Market - Industry Outlook & Forecast 2024-2029
THE U.S. CLINICAL LABORATORY TESTS MARKET IS GROWING AT A CAGR OF 2.17% AND IT IS EXPECTED TO REACH USD 109.09 BILLION BY 2029 FROM USD 95.89 BILLION IN 2023 DURING THE FORECAST PERIOD.
The U.S. Clinical Laboratory Tests Market Size, Share, & Trends Analysis Report By
- Test Complexity: Specialty Tests and Routine Tests
- Providers: Hospital-based Clinical Laboratory, Independent Laboratories, Physician Office Laboratories (PLOS), and Others
- Test Type: Clinical & Immunochemistry, Molecular Diagnostics, Hematology, Microbiology & Cytology, and Toxicology
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
U.S. CLINICAL LABORATORY TESTS MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (2029) | USD 109.09 Billion |
| Market Size (2023) | USD 95.89 Billion |
| CAGR (2023-2029) | 2.17% |
| HISTORIC YEAR | 2020-2022 |
| BASE YEAR | 2023 |
| Forecast Year | 2024-2029 |
| Market Segments | Test Complexity, Providers, and Test Type |
| Geographic Analysis | United States |
| KEY PLAYERS | Eurofins Scientific, Laboratory Corporation of America, Mayo Clinic Laboratories, OPKO Health, Inc. (BioReference Health), Quest Diagnostics, Siemens Healthineers, and Sonic Healthcare |
U.S. Clinical Laboratory Tests Market Size
The U.S. clinical laboratory tests market size reached $95.89 billion in 2023 and is projected to grow to $109.09 billion by 2029. Clinical laboratory tests involve the collection of biological samples such as blood, urine, or tissue from patients. These samples are processed and analyzed by trained medical professionals using specialized laboratory equipment and methods.
The industry is both diverse and complex, with a wide network of clinical laboratory providers offering thousands of test options to help manage and monitor patient health. Across the country, about 75% of medical decisions, including diagnosis, treatment, and ongoing patient care, depend on clinical laboratory test results. The deep integration of laboratories into the U.S. healthcare system has fueled steady market growth.
MARKET TRENDS AND OPPORTUNITIES
Technological Integration Driving Growth
Advancements in computing power, automation, and precision instruments have revolutionized laboratory operations. Manual testing has largely been replaced by compact, high-throughput systems. The U.S. clinical laboratory tests market size has expanded rapidly through the adoption of robotics, artificial intelligence, machine learning, and cloud-based patient data management. AI is now a critical tool, analyzing vast datasets to uncover patterns and relationships between diseases, environmental factors, and genetics, supporting earlier detection and the rise of personalized medicine.
Hospital-Laboratory Integration
As demand for testing grows, hospitals are increasingly partnering with established labs to enhance diagnostic capabilities. These collaborations allow healthcare providers to deliver faster, more accurate results. For example, LabCorp manages Ascension Hospital labs in ten U.S. states, offering various partnership models to improve access to lab services nationwide.
Increasing Utilization of Lab Tests
With around 14 billion tests conducted annually, laboratory testing is the most widely used medical service in the U.S. In 2021, Medicare spending on lab tests reached USD 10 billion, a 17% increase from the previous year.
Focus on Early and Preventive Diagnosis
U.S. healthcare culture emphasizes early detection and prevention, resulting in a significantly higher testing volume compared to other nations. This cultural approach continues to fuel growth in the U.S. clinical laboratory tests market size.
SEGMENTATION INSIGHTS
By Test Complexity
Specialty tests, though performed less frequently than routine tests, dominate revenue share due to higher pricing. More than 30% of tests fall under this category, which includes moderately and highly complex procedures. Genetic testing is one of the fastest-growing segments.
By Providers
Hospital-based laboratories lead the market, serving both inpatient and outpatient needs. These labs typically perform a larger volume of tests than independent or physician office labs. Growing demand for integrated lab services is driving partnerships between hospitals and major players like Quest Diagnostics and LabCorp.
By Test Type
Clinical and immunochemistry tests hold the largest share, driven by their role in identifying biomolecules, detecting immune disorders, and ensuring compatibility in organ transplants. Subcategories such as enzymology, toxicology, and endocrinology also contribute significantly to revenue.
COMPETITIVE LANDSCAPE
The U.S. clinical laboratory tests market size is highly competitive, with both domestic and international players. Large independent labs like LabCorp and Quest Diagnostics dominate alongside hospital-based and physician office laboratories. Consolidation is expected to continue as health systems expand their testing capabilities.
Key players include LabCorp, Quest Diagnostics, Sonic Healthcare, and OPKO Health. The market remains fragmented yet challenging, with competition driven by service quality, technology adoption, and geographic reach.
SNAPSHOT
The U.S. clinical laboratory tests market size is expected to grow at a CAGR of approximately 2.17% from 2023 to 2029.
The following factors are likely to contribute to the growth of the U.S. clinical laboratory tests market during the forecast period:
- Genetic Testing in the Mainstream
- The Increasing Utilization of Clinical Lab Tests
- High Demand for Early & Preventive Diagnosis
Base Year: 2023
Forecast Year: 2024-2029
The report considers the present scenario of the U.S. clinical laboratory tests market and its market dynamics for 2024−2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
- Eurofins Scientific
- Business Overview
- Product Offerings
- Key Strategies
- Key Strengths
- Key Opportunities
- Laboratory Corporation of America
- Mayo Clinic Laboratories
- OPKO Health, Inc. (BioReference Health)
- Quest Diagnostics
- Siemens Healthineers
- Sonic Healthcare
Other Prominent Vendors
- Accu Reference Medical Labs
- Business Overview
- Product Offerings
- ARUP Laboratories
- Clinical Reference Laboratory
- DaVita
- Empire City Laboratories
- Fresenius Medical Care
- HealthTrackRx
- Laboratory of Florida
- Millenium Health
- US Speciality Labs
Segmentation by Test Complexity
- Specialty Tests
- Routine Tests
Segmentation by Providers
- Hospital-based Clinical Laboratory
- Independent Laboratories
- Physician Office Laboratories (PLOS)
- Others
Segmentation by Test Type
- Clinical & Immunochemistry
- Molecular Diagnostics
- Hematology
- Microbiology & Cytology
- Toxicology
U.S. CLINICAL LABORATORY TESTS MARKET FAQs
How big is the U.S. clinical laboratory tests market?
What is the growth rate of the U.S. clinical laboratory tests market?
Which provider segment dominates the U.S. clinical laboratory tests market share?
What are the significant trends in the U.S. clinical laboratory tests market?
Who are the key players in the U.S. clinical laboratory tests market?
EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023
EXHIBIT 2 OVERVIEW OF US CLINICAL LABORATORY TESTS MARKET 2023–2029
EXHIBIT 3 DYNAMICS OF US CLINICAL LABORATORY TESTS MARKET
EXHIBIT 4 SEGMENTATION OF US CLINICAL LABORATORY TESTS MARKET
EXHIBIT 5 CLINICAL LABORATORY PROCESSES
EXHIBIT 6 IMPORTANCE OF CLINICAL LABORATORY TESTS IN HEALTHCARE
EXHIBIT 7 IMPACT OF ADVANCES AND INTEGRATION OF TECHNOLOGIES IN CLINICAL LAB TESTING
EXHIBIT 8 TECHNOLOGIES INTEGRATED IN CLINICAL LABS
EXHIBIT 9 IMPACT OF HOSPITALS INTEGRATED WITH CLINICAL LABORATORIES
EXHIBIT 10 IMPACT OF TELEMEDICINE & DIRECT-TO-CONSUMER SOLUTIONS PROVIDE NEW OPPORTUNITIES
EXHIBIT 11 ADVANTAGES OF DIRECT-TO-CONSUMER TESTS
EXHIBIT 12 IMPACT OF RAPIDLY GROWING DEMAND FOR GENETIC TESTING
EXHIBIT 13 IMPACT OF INCREASE IN UTILIZATION OF CLINICAL LAB TESTS
EXHIBIT 14 CLINICAL LABORATORY TESTS PERFORMED FROM 2015 TO 2023 IN US (BILLION)
EXHIBIT 15 IMPACT OF HIGH DEMAND FOR EARLY & PREVENTIVE DIAGNOSIS
EXHIBIT 16 THREE PILLARS OF PREVENTIVE HEALTHCARE IN US
EXHIBIT 17 IMPACT OF COMPLEXITY AND ETHICAL ISSUES WITH LABORATORY TESTS
EXHIBIT 18 CLINICAL LABORATORIES & ETHICAL DILEMMAS
EXHIBIT 19 IMPACT OF INCREASE IN BURDEN OF INAPPROPRIATE CLINICAL LAB TESTING
EXHIBIT 20 IMPACT OF PREFERENCE FOR POINT-OF-CARE TESTING CHALLENGES THE UTILIZATION OF CLINICAL LAB TESTS
EXHIBIT 21 US CLINICAL LABORATORY TESTS MARKET 2023–2029: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 22 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY 2023–2029 (% SHARE)
EXHIBIT 23 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS 2023–2029 (% SHARE)
EXHIBIT 24 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE 2023–2029 (% SHARE)
EXHIBIT 25 US CLINICAL LABORATORY TESTS MARKET 2020-2029 ($ BILLION)
EXHIBIT 26 FIVE FORCES ANALYSIS 2023
EXHIBIT 27 INCREMENTAL GROWTH BY TEST COMPLEXITY 2023 & 2029
EXHIBIT 28 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY 2023–2029
EXHIBIT 29 OVERVIEW OF US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY
EXHIBIT 30 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY: INCREMENTAL GROWTH
EXHIBIT 31 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY: ABSOLUTE GROWTH
EXHIBIT 32 US CLINICAL LABORATORY TESTS MARKET BY SPECIALTY TEST: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 33 US SPECIALTY CLINICAL LABORATORY TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 34 US CLINICAL LABORATORY TESTS MARKET BY ROUTINE TEST: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 35 US ROUTINE CLINICAL LABORATORY TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 36 INCREMENTAL GROWTH BY PROVIDERS SEGMENT 2023 & 2029
EXHIBIT 37 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS 2023–2029
EXHIBIT 38 TYPES OF LABS & TEST VOLUME OF CLINICAL LABS IN US
EXHIBIT 39 OVERVIEW OF US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS
EXHIBIT 40 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 41 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS: ABSOLUTE GROWTH
EXHIBIT 42 US CLINICAL LABORATORY TESTS MARKET BY HOSPITAL-BASED LABORATORIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 43 US HOSPITAL-BASED CLINICAL LABORATORY TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 44 US CLINICAL LABORATORY TESTS MARKET BY INDEPENDENT LABORATORIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 45 US INDEPENDENT CLINICAL LABORATORY TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 46 PHYSICIAN OFFICE LABORATORIES OPERATE UNDER VARIOUS SECTIONS
EXHIBIT 47 US CLINICAL LABORATORY TESTS MARKET BY PHYSICIAN OFFICE LABORATORIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 48 US PHYSICIAN OFFICE CLINICAL LABORATORY TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 49 US CLINICAL LABORATORY TESTS MARKET BY OTHERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 50 US OTHERS CLINICAL LABORATORY TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 51 INCREMENTAL GROWTH BY TEST TYPE 2023 & 2029
EXHIBIT 52 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE 2023–2029
EXHIBIT 53 OVERVIEW OF US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE
EXHIBIT 54 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE: INCREMENTAL GROWTH
EXHIBIT 55 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE: ABSOLUTE GROWTH
EXHIBIT 56 US CLINICAL LABORATORY TESTS MARKET BY CLINICAL & IMMUNOCHEMISTRY: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 57 US CLINICAL LABORATORY TESTS MARKET BY CLINICAL & IMMUNOCHEMISTRY 2020–2029 ($ BILLION)
EXHIBIT 58 GENETIC TESTING IN THE US 2023
EXHIBIT 59 US CLINICAL LABORATORY TESTS MARKET BY MOLECULAR DIAGNOSTICS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 60 US CLINICAL LABORATORY TESTS MARKET BY MOLECULAR DIAGNOSTICS 2020–2029 ($ BILLION)
EXHIBIT 61 US CLINICAL LABORATORY TESTS MARKET BY HEMATOLOGY: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 62 US HEMATOLOGY CLINICAL LABORATORY TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 63 US CLINICAL LABORATORY TESTS MARKET BY MICROBIOLOGY & CYTOLOGY TESTS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 64 US CLINICAL LABORATORY TESTS MARKET BY MICROBIOLOGY & CYTOLOGY 2020–2029 ($ BILLION)
EXHIBIT 65 APPLICATIONS OF TOXICOLOGY TESTS
EXHIBIT 66 TOXICOLOGY LABORATORIES BY OWNERSHIP IN US 2021
EXHIBIT 67 US CLINICAL LABORATORY TESTS MARKET BY TOXICOLOGY: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 68 US CLINICAL LABORATORY TESTS MARKET BY TOXICOLOGY 2020–2029 ($ BILLION)
EXHIBIT 69 CLINICAL LABORATORIES STATISTICS IN US 2023
EXHIBIT 70 QUEST DIAGNOSTICS AND LABCORP IN US MARKET 2023 (% SHARE)
EXHIBIT 71 ANNUAL REVENUE OF EUROFINS SCIENTIFIC 2020–2022 ($ BILLION)
EXHIBIT 72 ANNUAL REVENUE OF LABORATORY CORPORATION OF AMERICA 2020–2022 ($ BILLION)
EXHIBIT 73 ANNUAL REVENUE OF OPKO HEALTH, INC 2020–2022 ($ BILLION)
EXHIBIT 74 ANNUAL REVENUE OF QUEST DIAGNOSTICS 2020–2022 ($ BILLION)
EXHIBIT 75 ANNUAL REVENUE OF SIEMENS HEALTHINEERS 2020–2022 ($ BILLION)
EXHIBIT 76 ANNUAL REVENUE OF DIAGNOSTICS SEGMENT OF SIMENS HEALTHINEERS 2020-2022 ($ BILLION)
EXHIBIT 77 ANNUAL REVENUE OF SONIC HEALTHCARE 2020-2022 ($ BILLION)
EXHIBIT 78 KEY CAVEATS
LIST OF TABLES
TABLE 1 FEDERAL AGENCIES UNDER CLIA ADMINISTRATION & THEIR RESPONSIBILITIES
TABLE 2 HOSPITALS INTEGRATED WITH TWO MAJOR CLINICAL LABS IN US
TABLE 3 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY 2023–2029 ($ BILLION)
TABLE 4 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY 2023–2029 (%)
TABLE 5 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS 2023–2029 ($ BILLION)
TABLE 6 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS 2023–2029 (%)
TABLE 7 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE 2023–2029 ($ BILLION)
TABLE 8 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE 2023–2029 (%)
TABLE 9 APPLICATIONS OF MICROBIOLOGY CLINICAL TESTING
TABLE 10 TYPE OF TOXICOLOGY TESTING PERFORMED BY RESPECTIVE TOXICOLOGY LABORATORIES & OWNERSHIP OF LABS
TABLE 11 EUROFINS SCIENTIFIC: MAJOR SERVICE OFFERINGS
TABLE 12 LABORATORY CORPORATION OF AMERICA: MAJOR SERVICE OFFERINGS
TABLE 13 MAYO CLINIC LABORATORIES: MAJOR SERVICE OFFERINGS
TABLE 14 OPKO HEALTH, INC: MAJOR SERVICE OFFERINGS
TABLE 15 QUEST DIAGNOSTICS: MAJOR SERVICE OFFERINGS
TABLE 16 SIEMENS HEALTHINEERS: MAJOR SERVICE OFFERINGS
TABLE 17 SONIC HEALTHCARE: MAJOR SERVICE OFFERINGS
TABLE 18 ACCU REFERENCE MEDICAL LABS: MAJOR SERVICE OFFERINGS
TABLE 19 ARUP LABORATORIES: MAJOR SERVICE OFFERINGS
TABLE 20 CLINICAL REFERENCE LABORATORY: MAJOR SERVICE OFFERINGS
TABLE 21 DAVITA: MAJOR SERVICE OFFERINGS
TABLE 22 EMPIRE CITY LABORATORIES: MAJOR SERVICE OFFERINGS
TABLE 23 FRESENIUS MEDICAL CARE: MAJOR SERVICE OFFERINGS
TABLE 24 HEALTHTRACKRX: MAJOR SERVICE OFFERINGS
TABLE 25 LABORATORY OF FLORIDA: MAJOR SERVICE OFFERINGS
TABLE 26 MILLENIUM HEALTH: MAJOR SERVICE OFFERINGS
TABLE 27 US SPECIALTY LABS: MAJOR SERVICE OFFERINGS
TABLE 28 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY 2023–2029 ($ BILLION)
TABLE 29 US CLINICAL LABORATORY TESTS MARKET BY TEST COMPLEXITY 2023–2029 (%)
TABLE 30 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS 2023–2029 ($ BILLION)
TABLE 31 US CLINICAL LABORATORY TESTS MARKET BY PROVIDERS 2023–2029 (%)
TABLE 32 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE 2023–2029 ($ BILLION)
TABLE 33 US CLINICAL LABORATORY TESTS MARKET BY TEST TYPE 2023–2029 (%)
TABLE 34 CURRENCY CONVERSION 2016−2023
1 SCOPE & COVERAGE
1.1 MARKET DEFINITION
1.1.1 INCLUSIONS
1.1.2 EXCLUSIONS
1.1.3 MARKET ESTIMATION CAVEATS
1.2 SEGMENT COVERED & DEFINITION
1.2.1 MARKET BY TEST COMPLEXITY
1.2.2 MARKEY BY PROVIDERS
1.2.3 MARKET BY TEST TYPE
1.3 MARKET DERIVATION
1.3.1 BASE YEAR
2 PREMIUM INSIGHTS
2.1 OPPORTUNITY POCKETS
2.2 OVERVIEW
2.2.1 MARKET TRENDS & OPPORTUNITIES
2.2.2 MARKET DRIVERS:
3 MARKET AT A GLANCE
4 INTRODUCTION
4.1 OVERVIEW
4.1.1 FEDERAL REGULATORY FOR LABORATORY MEDICINE
4.1.2 IMPACT OF COVID-19 PANDEMIC
5 MARKET OPPORTUNITIES & TRENDS
5.1 ADVANCES AND INTEGRATION OF TECHNOLOGIES IN CLINICAL LAB TESTING
5.2 HOSPITALS INTEGRATED WITH CLINICAL LABORATORIES
5.3 TELEMEDICINE AND DIRECT-TO-CONSUMER SOLUTIONS PROVIDE NEW OPPORTUNITIES
6 MARKET GROWTH ENABLERS
6.1 RAPIDLY GROWING DEMAND FOR GENETIC TESTING
6.2 INCREASE IN UTILIZATION OF CLINICAL LAB TESTS
6.3 HIGH DEMAND FOR EARLY & PREVENTIVE DIAGNOSIS
7 MARKET RESTRAINTS
7.1 COMPLEXITY AND ETHICAL ISSUES WITH LABORATORY TESTS
7.2 INCREASE IN BURDEN OF INAPPROPRIATE CLINICAL LAB TESTING
7.3 PREFERENCE FOR POINT-OF-CARE TESTING CHALLENGES THE UTILIZATION OF CLINICAL LAB TESTS
8 MARKET LANDSCAPE
8.1 MARKET OVERVIEW
8.2 MARKET SIZE & FORECAST
8.3 FIVE FORCES ANALYSIS
8.3.1 THREAT OF NEW ENTRANTS
8.3.2 BARGAINING POWER OF SUPPLIERS
8.3.3 BARGAINING POWER OF BUYERS
8.3.4 THREAT OF SUBSTITUTES
8.3.5 COMPETITIVE RIVALRY
9 TESTS COMPLEXITY
9.1 MARKET SNAPSHOT & GROWTH ENGINE
9.2 MARKET OVERVIEW
9.3 MARKET BY TEST COMPLEXITY
9.4 SPECIALTY TESTS
9.4.1 MARKET OVERVIEW
9.4.2 MARKET SIZE & FORECAST
9.5 ROUTINE TESTS
9.5.1 MARKET OVERVIEW
9.5.2 MARKET SIZE & FORECAST
10 PROVIDERS
10.1 MARKET SNAPSHOT & GROWTH ENGINE
10.2 MARKET OVERVIEW
10.3 MARKET BY PROVIDERS
10.4 HOSPITAL-BASED LABORATORIES
10.4.1 MARKET OVERVIEW
10.4.2 MARKET SIZE & FORECAST
10.5 INDEPENDENT LABORATORIES
10.5.1 MARKET OVERVIEW
10.5.2 MARKET SIZE & FORECAST
10.6 PHYSICIAN OFFICE LABORATORIES (POLS)
10.6.1 MARKET OVERVIEW
10.6.2 MARKET SIZE & FORECAST
10.7 OTHERS
10.7.1 MARKET OVERVIEW
10.7.2 MARKET SIZE & FORECAST
11 TEST TYPE
11.1 MARKET SNAPSHOT & GROWTH ENGINE
11.2 MARKET OVERVIEW
11.3 MARKET BY TEST TYPE
11.4 CLINICAL & IMMUNOCHEMISTRY
11.4.1 MARKET OVERVIEW
11.4.2 MARKET SIZE & FORECAST
11.5 MOLECULAR DIAGNOSTICS
11.5.1 MARKET OVERVIEW
11.5.2 MARKET SIZE & FORECAST
11.6 HEMATOLOGY
11.6.1 MARKET OVERVIEW
11.6.2 MARKET SIZE & FORECAST
11.7 MICROBIOLOGY & CYTOLOGY
11.7.1 MARKET OVERVIEW
11.7.2 MARKET SIZE & FORECAST
11.8 TOXICOLOGY
11.8.1 MARKET OVERVIEW
11.8.2 MARKET SIZE & FORECAST
12 COMPETITIVE LANDSCAPE
12.1 COMPETITION OVERVIEW
12.2 MARKET SHARE ANALYSIS
12.2.1 EUROFINS SCIENTIFIC
12.2.2 LABORATORY CORPORATION OF AMERICA (LABCORP)
12.2.3 MAYO CLINIC LABORATORIES
12.2.4 OPKO HEALTH (BIOREFERENCE HEALTH)
12.2.5 QUEST DIAGNOSTICS
12.2.6 SIEMENS HEALTHINEERS
12.2.7 SONIC HEALTHCARE
13 KEY COMPANY PROFILES
13.1 EUROFINS SCIENTIFIC
13.1.1 BUSINESS OVERVIEW
13.1.2 SERVICE OFFERINGS
13.1.3 KEY STRATEGIES
13.1.4 KEY STRENGTHS
13.1.5 KEY OPPORTUNITIES
13.2 LABORATORY CORPORATION OF AMERICA
13.2.1 BUSINESS OVERVIEW
13.2.2 SERVICE OFFERINGS
13.2.3 KEY STRATEGIES
13.2.4 KEY STRENGTHS
13.2.5 KEY OPPORTUNITIES
13.3 MAYO CLINIC LABORATORIES
13.3.1 BUSINESS OVERVIEW
13.3.2 SERVICE OFFERINGS
13.3.3 KEY STRATEGIES
13.3.4 KEY STRENGTHS
13.3.5 KEY OPPORTUNITIES
13.4 OPKO HEALTH, INC (BIOREFERENCE HEALTH)
13.4.1 BUSINESS OVERVIEW
13.4.2 SERVICE OFFERINGS
13.4.3 KEY STRATEGIES
13.4.4 KEY STRENGTHS
13.4.5 KEY OPPORTUNITIES
13.5 QUEST DIAGNOSTICS
13.5.1 BUSINESS OVERVIEW
13.5.2 SERVICE OFFERINGS
13.5.3 KEY STRATEGIES
13.5.4 KEY STRENGTHS
13.5.5 KEY OPPORTUNITIES
13.6 SIEMENS HEALTHINEERS
13.6.1 BUSINESS OVERVIEW
13.6.2 SERVICE OFFERINGS
13.6.3 KEY STRATEGIES
13.6.4 KEY STRENGTHS
13.6.5 KEY OPPORTUNITIES
13.7 SONIC HEALTHCARE
13.7.1 BUSINESS OVERVIEW
13.7.2 SERVICE OFFERINGS
13.7.3 KEY STRATEGIES
13.7.4 KEY STRENGTHS
13.7.5 KEY OPPORTUNITIES
14 OTHER PROMINENT VENDORS
14.1 ACCU REFERENCE MEDICAL LABS
14.1.1 BUSINESS OVERVIEW
14.1.2 SERVICE OFFERINGS
14.1.3 KEY STRATEGIES
14.1.4 KEY STRENGTHS
14.1.5 KEY OPPORTUNITIES
14.2 ARUP LABORATORIES
14.2.1 BUSINESS OVERVIEW
14.2.2 SERVICE OFFERINGS
14.2.3 KEY STRATEGIES
14.2.4 KEY STRENGTHS
14.2.5 KEY OPPORTUNITIES
14.3 CLINICAL REFERENCE LABORATORY
14.3.1 BUSINESS OVERVIEW
14.3.2 SERVICE OFFERINGS
14.3.3 KEY STRATEGIES
14.3.4 KEY STRENGTHS
14.3.5 KEY OPPORTUNITIES
14.4 DAVITA
14.4.1 BUSINESS OVERVIEW
14.4.2 SERVICE OFFERINGS
14.4.3 KEY STRATEGIES
14.4.4 KEY STRENGTHS
14.4.5 KEY OPPORTUNITIES
14.5 EMPIRE CITY LABORATORIES
14.5.1 BUSINESS OVERVIEW
14.5.2 SERVICE OFFERINGS
14.5.3 KEY STRATEGIES
14.5.4 KEY STRENGTHS
14.5.5 KEY OPPORTUNITIES
14.6 FRESENIUS MEDICAL CARE
14.6.1 BUSINESS OVERVIEW
14.6.2 SERVICE OFFERINGS
14.6.3 KEY STRATEGIES
14.6.4 KEY STRENGTHS
14.6.5 KEY OPPORTUNITIES
14.7 HEALTHTRACKRX
14.7.1 BUSINESS OVERVIEW
14.7.2 SERVICE OFFERINGS
14.7.3 KEY STRATEGIES
14.7.4 KEY STRENGTHS
14.7.5 KEY OPPORTUNITIES
14.8 LABORATORY OF FLORIDA
14.8.1 BUSINESS OVERVIEW
14.8.2 SERVICE OFFERINGS
14.8.3 KEY STRATEGIES
14.8.4 KEY STRENGTHS
14.8.5 KEY OPPORTUNITIES
14.9 MILLENNIUM HEALTH
14.9.1 BUSINESS OVERVIEW
14.9.2 SERVICE OFFERINGS
14.9.3 KEY STRATEGIES
14.9.4 KEY STRENGTHS
14.9.5 KEY OPPORTUNITIES
14.10 US SPECIALTY LABS
14.10.1 BUSINESS OVERVIEW
14.10.2 SERVICE OFFERINGS
14.10.3 KEY STRATEGIES
14.10.4 KEY STRENGTHS
14.10.5 KEY OPPORTUNITIES
15 REPORT SUMMARY
15.1 KEY TAKEAWAYS
15.2 STRATEGIC RECOMMENDATIONS
16 QUANTITATIVE SUMMARY
16.1 MARKET BY TEST COMPLEXITY
16.2 MARKET BY PROVIDERS
16.3 MARKET BY TEST TYPE
17 APPENDIX
17.1 RESEARCH METHODOLOGY
17.2 RESEARCH PROCESS
17.3 REPORT ASSUMPTIONS & CAVEATS
17.3.1 KEY CAVEATS
17.3.2 CURRENCY CONVERSION
17.4 ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
How big is the U.S. clinical laboratory tests market?
What is the growth rate of the U.S. clinical laboratory tests market?
Which provider segment dominates the U.S. clinical laboratory tests market share?
What are the significant trends in the U.S. clinical laboratory tests market?
Who are the key players in the U.S. clinical laboratory tests market?
U.S. Clinical Laboratory Tests Market Report
Other RELATED Reports
 Market - Global Outlook and Forecast 2021-2026-1617699358.png)
Laboratory Information Management System (LIMS) Market - Global Outlook and Forecast 2021-2026
Published : April 2021
Laboratory Equipment and Consumables Market - Global Outlook & Forecast 2023-2028
Published : September 2023